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o Abstract - Mixed allogeneic cbimerism (A + B ..... Al was 
induced in rats by reconstitution of let bally irradiated LEW 
recipients with a mixture of T-cell depleted (TCm syngeneic 
and TCD allogeneic ACI bone marrow. Thirty-seven percent 
of animals repopulated as stable mixed Iympbopoietic chi-
meras. while the remainder had no detectable allogeneic 
chimerism. When evaluated for evidence of donor-specific 
transplantation tolerance, only tbose recipients with detect-
able allogeneic Iympboid chimerism exbibited acceptance of 
donor-specific skin and cardiac allografts. Despite transplan-
tation over a major histocompatibility complex (MHC)- and 
minor-disparate barrier, animaJs accepted donor-specific 
ACI skin and primarily vascularized cardiac allografts per-
manently, while rejecting third pany Brown Norway (BN) 
grafts. The tolerance induced was aJso donor-specific in vitro 
as evidenced by specific hyporeactivity to the allogeneic 
donor lymphoid elements. yet normal reactivity to MHC-
disparate third party rat Iympboid cells. This model for 
mixed chimerism in the rat will be advantageous to investi-
gate specific transplantation tolerance to primarily vascular-
ized solid organ grafts that can be performed with relative 
ease in the rat. but not in the mouse. and may provide a 
method to study the potential existence of organ- or tissue-
specific alloantigens in primarily vascularized solid organ 
allografts. 
o Keywords - Bone marrow; Transplantation tolerance; 
Chimerism: Skin. 
INTRODUCTION 
I n clinical transplantation. nonspecific immunosup-
pressive agents are required to control the rejection re-
sponse. In their action, these agents suppress rejection 
of genetically different grafts, but they also suppress 
other immune responses to unrelated antigens such as 
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virus or opportunistic organisms. In order to overcome 
these limitations. specific tolerance to allogeneic donor 
grafts with preservation of host immunocompetence 
has become a goal of transplantation today. In recent 
years, a number of methods have been developed to in-
duce donor specific transplantation tolerance using 
bone marrow transplantation (1,4,13,14,16,18). One 
approach, using bone marrow transplantation (BMT) 
with a mixture of syngeneic and allogeneic bone mar-
row (BM) to prepare mixed allogeneic chimeras (A + 
B -+ A), has been shown to be effective and useful to 
achieve long-term donor-specific transplantation toler-
ance to alloantigens in mice (8). This regimen is advan-
tageous over fully allogeneic (A -+ B) transplantation 
models. because mixed chimeras exhibit superior im-
munocompetence to eliminate virus or produce anti-
body when compared with fully allogeneic chimeras 
due to the presence of resuisite host-type antigen pre-
senting cells (APCs) for T-cell activation and function 
(8,17). 
Transplantation of vascularized solid organ grafts 
in mice has experienced limited success due to techni-
cal difficulties based upon vessel size. In contrast. 
transplantation of organs such as heart. small bowel. 
and liver can be performed with relative ease in the rat. 
Therefore, we adapted the model of mixed chimerism 
to the rat. which has allowed us to investigate the re-
sponse of mixed allogeneic chimeras to skin and pri-
marily vascularized solid organ. 
The initial reports using allogeneic chimerism to in-
duce donor-specific transplantation tolerance in the 
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mouse were preformed using congenic strain combina-
tions disparate only in major histocompatibility com-
plex (MHC), but matched for the minor region (9). 
When noncongenic strain combinations were utilized 
(BIO + C3H - BIO), donor-specific skin grafts under-
went a slow chronic rejection (9). In spite of this, ani-
mals remained chimeric. In addition, when con genic 
skin matched to the MHC of the donor (H-2k), but 
(he minor antigens of the recipient (BIO) was placed, 
it was permanently accepted (9). This was attributed 
to skin-specific antigens encoded in the minor region 
of the genetic locus present on the skin, but not on the 
bone marrow cells to which the recipient was rendered 
tolerant, similar to those previously described for fully 
allogeneic chimeras (3,21,22). The induction of mixed 
chimerism in the rat has now allowed us to evaluate 
whether skin-specific antigens may also exist in this 
species. 
In our present experiments we report that stable 
mixed lymphopoietic chimerism can be established in 
the raL \10reover, donor-specific skin and cardiac 
graft acceptance occurred over an MHC and non-
MHC barrier to skin and primarily vascularized car-
diac allografts without evidence of chronic rejection 
for up to 150 days. This tolerance was donor-specific 
in vitro when evaluated by mixed lymphocyte reaction 
(MLR). The model of allogeneic chimerism using the 
rat will provide a method to study donor-specific trans-
plantation tolerance to other primarily vascularized 
allogeneic grafts. and to evaluate for potential tissue 
or organ-specific alloantigens. 
\1ATERIALS AND METHODS 
Animals 
\l1ale LEW (Rn l ), ACI (RTF), and BN (Rt! 0) rats 
(225-250 g) were purchased from Harlan Sprague-
Dawley (Indianapolis, IN), and maintained in a laminar 
flow caging system (Thoren Caging Systems, Hazelton, 
PAl. Animals were given acidified water containing 
neomycin sulfate, 10 mL per liter. 
Mixed Bone Marrow Reconstitution 
(LEW + ACI .... LEW) Recipient LEW animals were 
lethally irradiated with 1000 rad total body irradiation 
(TBI) delivered from a J37Cs source. BM was har-
vested from tibias and femurs of ACI and LEW do-
nor rats. washed, and resuspended in Hanks' balanced 
salt solution (HBSS), supplemented with gentamicin 
30 tLL/mL. T-cell depletion was performed using mag-
netic polymer beads (Dynabeads M4501, Bioproducts 
for Science. Indianapolis. IN) coated with MAb OX-19 
(anti-CDS). Beads were prepared by incubating the 
magnetic particles with fetal bovine serum (FCS) 
(Gibco. Grand Island, NY), at 290 ILL! FCS/mL of 
beads for 24 h, followed by OX-19 (29 J.LIImL of beads) 
for 24 h. ACI and LEW BM inocula were separately 
T -cell depleted using a ratio of beads/T cell of 1 :20 for 
ACI and 1 :40 for LEW cells. The beads/marrow mix-
ture was incubated at room temperature for 30 min with 
constant gentle rotation. Separation of the beads/T 
cell complex from the depleted marrow was achieved 
by placing the beads/marrow mixture in a magnetic 
field. Flow cytometric analysis on spleen controls were 
performed routinely to assess successful depletion of 
OX-19 (anti-CDS) positive T cells. Mixed aIlogeneically 
reconstituted animals received 7 x 106 syngeneic TCD 
bone marrow cells and 43 x 106 allogeneic TCD bone 
marrow cells. Such animals will be referred to as mixed 
allogeneic. or LEW + ACI - LEW. Syngeneically re-
constituted controls received 50 x 106 TCD syngeneic 
bone marrow cells (LEW ..... LEW). Radiation controls 
were performed simultaneously to confirm the ade-
quacy of the lethal dose of irradiation. 
Assessment of Chimerism by Flow Cytometry 
F our weeks after reconstitution, rats receiving a 
mixed syngeneic + allogeneic BMT were assessed for 
the presence of allogeneic donor type (ACl) cells. In 
typing for chimerism, mAb were used to detect MHC 
Class I antigens. Monoclonal antibody 163 (lg G2b) is 
specific for the RTl.AI antigen on LEW cells, whereas 
mAb 211 (Ig G2b) is specific for the RTl.Aa antigen 
on ACI cells (7,11). MAb 42 (RT l.A n) was used as an 
irrelevant control (mAb 163, 211, and 42 were kindly 
provided by H. W. Kunz, University of Pittsburgh, 
Department of Pathology, Pittsburgh, PAl. All three 
antibodies were tested against each strain used with no 
detectable cross reactivity. For surface marker analy-
sis. 1 x 105 cells obtained from Ficoll Hypaque gradi-
ent centrifugation of peripheral blood. were placed in 
100 mL of HBSS. The MAbs 163, 211, and 42 were 
added as primary biotinylated antibodies at 1 :50 dilu-
tion, and incubated for 60 min at 4°C. The cells were 
washed twice with HBSS and 0.1070 gelatin, and resus-
pended in fluorescein isothiocyanate (FITC) as a sec-
ondary marker. After 1 h at 4°C, cells were washed 
three times with HBSS and 0.1 % gelatin, and resus-
pended in 1% paraformaldehyde. 
Skin Grafting 
Full thickness skin grafts were prepared using a 
modification of the method of Billingham (2). Full 
thickness tail skin of donor (ACI), third pany (BN) 
and host-type (LEW), were placed on the pannicu-
lus carnosus of the posterior and lateral thoracic wall. 
Rejection was diagnosed when 90% of the graft was 
necrotic. 
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Cardiac Transplantation 
A heterotopic abdominal heart transplantation 
model was used in these experiments (15). Briefly, ACI 
donor animals were anesthetized and heparinized with 
150 units heparin IV. The thoracic cavity was opened. 
and the IVC and the SVC were ligated and divided. The 
aorta and pulmonary artery were transected 3-5 mm 
distally to their origins. A mass ligature was placed 
around the pulmonary vein. and the heart was then re-
moved and stored at 4°C in cold Ringers lactate. The 
recipient vena cava and abdominal aorta were oc-
cluded, and an aortotomy and venotomy were per-
formed. End-to-side anastomosis of the aorta to the 
recipient abdominal aorta. and of the pulmonary ar-
tery to the recipient vena cava were completed. Sur-
vival of recipient animals. and skin and cardiac grafts 
were calculated by the life table method (6). 
,'vIixed Lymphocyte Reaction (MLR) 
\tLR assays were periormed by a modified method 
as previously described (9). Briefly, lymph nodes were 
removed under sterile conditions. and an ACK lysed 
single cell suspension prepared in RPMI medium con-
taining O. 75()70 fresh normal rat serum. I mM glutamine. 
0.05 mM 2-mercaptOethanol. 0.1 mM nonessential 
amino acids. 1 mM Na-pyruvate. and 0.27070 gentami-
cin (all from GIBCO). Two x 105 stimulator cells 
(2000 rad) and 1 x 105 responder cells. each in a vol-
ume of 100 /-LL were placed in the 96-weil. round bot-
tom Linbro plate (Flow Lab .• McLean. VA). Cultures 
were incubated at 37° in 5070 CO2 for 4 days, pulsed 
on the third day with 1 /-LCi of [JHJ Thymidine (New 
England Nuclear. BostOn. ~lAF harvested 18 h later. 
and counted in a beta scintillation counter (Beckman. 
Palo Alto. CA). 
RESULTS 
T-Cell Depletion Using Beads 
Titrations were performed to determine the optimal 
number of beads required to achieve TCD of the rat 
bone marrow of both syngeneic (LEW) and allogeneic 
(AC!) donors. Complete removal of OX-19 positive T 
ceils was achieved when the beadlT cell ratio was 20: 1 
for ACI and 40: 1 for LEW cells. Adequacy of deple-
tions was confirmed using !low cytometry with mono-
donal antibody staining. 
Titrallon of T-Cell Depleted Syngeneic 
and Allogeneic Bone Marrow Cells 
to Achieve Survival 
Syngeneic and Allogeneic reconstitutions were per-
formed using tit rations of TCD bone marrow to deter-
mine the minimum number of infused ceils to allow 
100070 survival of lethally irradiated recipient rats_ One 
hundred percent survival (SIS) of syngeneic recipi-
ents (LEW ..... LEW) was achieved when a minimum 
of 7 x 106 TCD LEW bone marrow cells per animal 
were infused. Fifty-seven percent (417) of animals 
which received 40 x 106 allogeneic bone marrow cells 
survived. Survival was similar with increasing cell num-
ber, because 50070 (3/6) or 570/0 (417) of recipients sur-
vived when 75 x 106 or ISO x 106 allogeneic cells per 
recipient were given respectively. Therefore, in consec-
utive experiments a mixture of a total of 50 x 106 cells 
in a ratio of 6: I (7 x 106 syngeneic LEW and 43 x 106 
allogeneic ACI cells) were given to each recipient. 
Survival OJ Mixed AI/ogeneically 
Reconstituted Rats 
Survival of recipients of the mixed syngeneic + allo-
geneic bone marrow inoculum was 96070 at 150 days 
(Fig. 1). Out of this group, 37070 of animals (19152) re-
populated as mixed chimeras with detectable syngeneic 
and allogeneic lymphoid elements. When analyzed sep-
arately, these animals exhibited excellent survival (93% 
at 150 days). Of the remaining animals. 60070 (31/52) 
repopulated as totally syngeneic and 3070 (2/52) died at 
a time similar to radiation controls (Fig. 1). Survival 
of mixed chimeras was compared to that of a group 
of animals transplanted with TCD (LEW ..... LEW) in 
which 100070 of the transplanted animals survived more 
than 150 days (Fig. 1). 
In an attempt to achieve more reliable engraftment 
of allogeneic bone marrow. we performed tit rations of 
increasing numbers of cells. When up to 200 x 106 
TCD syngeneic + allogeneic bone marrow ceils. mixed 
in the same 6: 1 ACI to LEW ratio were infused per an-
imal. no improvement in allogeneic bone marrow ac-
ceptance resulted. 
Five out of 13 (38070) of the transplanted animals re-
populated as true mixed chimeras. The remaining 8 re-
populated as totally syngeneic when assessed 4 wk after 
BMT. All radiation controls expired within 16 days. 
Assessment oj Chimerism 
Four weeks after BMT, animals were tested for the 
presence of host and donor type peripheral blood 
lymphoid elements using flow cytometry. Cell surface 
phenotype of peripheral blood lymphocytes (PBL) was 
demonstrated using rat-ant i-rat monoclonal antibod-
ies specific for anti-Class I staining (Fig. 2). Animals 
were subsequently reevaluated at 15 and 21 wk after 
reconstitution to assess potential fluctuations in the 
percentage of chimerism throughout the study. In ar-
tificial titrations performed by mixing ACI and LEW 
lymphoid cells in varying ratios, chimerism could be 





0) 60 c 
n I Reclplenta 
'5 52 ~ Mixed Al~1y ReconstilUlad 
K~ 50 
:::J 
8 0--0 Syngeneically ReconSlitutlld 






10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 
Days Post Reconstitution 
Fig. 1. Survival of the rats reconstituted with mixed allogeneic (LEW + ACt --+ LEW) or syngeneic (LEW --+ LEW) bone marrow 
as calculated by the life table method (6). Irradiation controls received 1000 rad TBI without 8M rescue. 
detected to O.SOJo donor type ACI cells by flow cyto-
metry staining. As shown in Table I, the percentage of 
donor type allogeneic cells varied from O.S to 82070. 
Animals with detectable mixed chimerism, as well as 
llEWIS CELL. 
CHI ..... I 
10 100 
those that typed syngeneically were analyzed for the 
presence of donor-specific transplantation tolerance 
in vivo using skin or primarily vascularized cardiac 
allografts. 
LZI 
(lot) FLUORESCENCE INTENSITY 
Fig. 2. Flow cytometric analysis of cell phenotype from LEW and ACI controls. two representative chimeric animals. Four 
wi< after bone marrow transplantation. penpheral blood lymphocytes were tested for the presence of donor type ACt lymphoid 
..:ells using mAb 163 (anti-LEW) and mAb 211 (anti-ACI) (a generous gift from Dr. HW Kunz). Overlay of staining profiles 
with LEW and ACI mAb is shown for LEW and ACI controls. Straining of PBL with both mAb is presented separately 
for chimera controls. Calculation of chimerism showed 63070 ACI cells for chimera I and 20070 donor type ACI cells for 
..:himera 2. These animals are the same as those represented in Table 1. 
._-_. -------------
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Table I. Flow cytometry typing of mixed allogeneically 
reconstituted rat with detectable allogeneic chimerism 
070 ACI Lymphoid 
cells in PBL 
weeks after BMTx Graft 
Animal 
(LEW = ACI- LEW) 4 15 21 Skin Cardiac 
Chimera 1 63 65 64 +* 
2 20 Z2 N/At + 
3 50 32 36 + 
4 5 1 2 + 
5 73 82 N/A + 
6 3 1 1 + 
7 36 49 49 + 
8 2 0.5 0 + 
9 0 0 1.5 + 
10 62 61 N/A + 
11 55 40 N/A + 
12 48 48 48 + 
13 62 36 N/A + 
14 77 78 N/A + 
15 0.5 1 3 + 
16 19 ZI N/A + 
Flow cytometric analysis was performed on PBl using mAb against 
lew (RTIL) and ACI (Rna) Class I MHC antigens. A MAD 
against BN (RTln) was used as an irrelevant control and subtracted 
from staining for calculation of percentage of chimerism. Values for 
each individual animal were normalized to 1001170. Only animals with 
detectable allogeneic chimerism are presented. 
-Graft viable. tN/A = Not Available. 
100 
90 t- n I 
Skin Graft Survival In Syngeneically and Mixed 
Allogeneically Reconstituted Animals 
Four weeks after BMT, each animal received three 
skin grafts: A syngeneic LEW (RTl I), a donor type 
allogeneic ACI (RTl a), and a MHC-disparate third 
party BN (RTl R) skin graft. All animals that had evi-
dence for engraftment of allogenic bone marrow when 
typed by flow cytometry also permanently accepted 
ACI (Fig. 3) and LEW skin (data not shown) grafts, 
yet rejected third party (BN) (data not shown) grafts 
in a similar time frame to negative controls. The level 
of allogeneic chimerism usually did not influence the 
outcome of skin graft survival as long as detectable chi-
merism was present. Even the 2 animals (animals 8 and 
9) that had only a very low level of detectable chime-
rism accepted donor-specific skin allografts. All animals 
that repopulated totally syngeneic following mixed al-
logeneic reconstitution were analyzed separately, and 
rejected donor-specific ACI and BN skin grafts in the 
time frame similar to unirradiated controls (Fig. 3). 
For virtually all recipients, donor-specific tolerance 
for skin graft acceptance occurred only in those ani-
mals with detectable allogeneic lymphoid chimerism, 
however low. One animal. animal #9, tested twice neg-
ative on 4 and IS wk, then had a low percentage chi-
merism at 21 wk. However. tolerance to donor-specific 
skin allografts was present in spite of a very low level 
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Days Following ACI Skin Graft 
Fig. 3. Life table survival of ACI skin grafts in mixed chimeras. Four wk after bone marrow transplantation. each animal 
received an ACI. LEW. and a BN full thickness skin graft. Animals which received mixed bone transplantation yet repopulated 
only syngeneically were analyzed separately. Grafts were followed for a minimum of 150 days. All animals accepted LEW 
skin grafts. but rejected third pany BN grafts (data not shown). 
.1 
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Histology of Donor-Specific Skin Grafts 
Skin grafts surviving for more than 150 days were 
examined histologically in a blinded fashion. The epi-
dermal-dermal architecture in the ACI grafts was sim-
ilar to those of LEW grafts performed as controls, with 
no histologic evidence suggestive of chronic rejection. 
No obvious cellular inflItrates or architectural changes 
were identified. 
Survival of Cardiac Allografts in Mixed 
Allogenica/ly Reconstituted Animals: 
Response to a Primarily Vascularized Graft 
Four weeks after BMT, six mixed allogeneically re-
constituted animals received a heterotopic ACI cardiac 
graft. Again. recipients of the mixed bone marrow in-
oculum. that had detectable allogeneic chimerism were 
analyzed separately from those animals that repopu-
lated as totally syngeneic. All mixed chimeric animals 
accepted the ACI donor heart graft permanently, with 
all grafts beating now for more than 150 days (Fig. 4). 
Syngeneically reconstituted LEW animals (n = 6) pre-
pared as controls that received an ACI cardiac graft 
rejected the graft with a time course similar to unma-
nipulated controls. 
Donor-Specific Tolerance as Assessed In Vitro by 
.\-fixed Lymphocyte Culture Proliferative (MLR) 
and Cellular Cytotoxicity (CML) Assay 
Animals that repopulated as true mixed lymphopoi-
etic chimeras were tested at 100 days post-BMT for 
their response to donor and third party alloantigens 
in MLR assays. As seen in a representative one way 
\1LR, lymph node cells obtained from mixed chime-
ric animals (LEW + ACI -+ Lew) were specifically non-
reactive to allogeneic donor (AC!) as well as syngeneic 
(LEW) stimulator cells. yet were competent to respond 
to MHC-disparate third party cells (Table 2). suggest-
ing the presence of systemic donor-specific transplan-
tation tolerance. 
DISCUSSION 
We report here a model to achieve stable mixed allo-
geneic chimerism in the rat using transplantation of a 
mixture of TCD syngeneic plus TCD allogeneic bone 
marrow. Because of the lack of complement-fixing 
anti-rat monoclonal antibodies for T-cell depletion, 
immunomagnetic beads were utilized. Despite manip-
ulation of allogeneic cell numbers administered. only 
approximately 40070 of animals were true mixed chime-
ras. Both bone marrow inocula (syngeneic plus alloge-
neic) were TCD prior to transplantation using mAb 
OX-19 to specifically deplete CD-5-positive cells. This 
model was then utilized to evaluate the recipients for 
donor-specific transplantation tolerance to skin and 
cardiac allografts in vivo as well as to donor lymphoid 
elements in vitro. 
Increasing the number of transplanted cells/animal 
did not overcome the limitation of failure engraftment 
of allogeneic bone marrow. Infusion up to 200 X 106 
BM cells per animals mixed in the same 6: 1 ACI:LEW 
ratio did not improve either the proportion of mixed 
chimeric animals or the level of engraftment of allo-
geneic donor type cells when engraftment was achieved. 
It is well recognized that syngeneic bone marrow en-
grafts more readily with fewer numbers of cells, when 
compared with allogeneic BM (5,23). Experiments in 
mice have shown that T-cell depletion of the syngeneic 
component of the mixed bone marrow inoculum is nec-
essary in order to allow engraftment of the allogeneic 
bone marrow cells when mixed allogeneic reconstitu-
tion is carried out (10). It is possible that the bead-
depletion using OX-19 did not remove all syngeneic T 
cells that prevent allogeneic stem cell engraftment. 
However. we feel that this is unlikely. because flow cy-
tometric analysis showed complete removal of OX-19 
positive T cells. The T-cell depletion protocol we ap-
plied was also not likely to remove stem cells, because 
engraftment of syngeneic BM was successful in 97070 
Table 2. Reactivity of mixed aliogeneically reconstituted animals 






Anti-self Anti-LEW Anti-ACI Anti-BN 
681 ± 122 25,264 ± 947 36.274 ± 3,735 
1,362 ± 174 1.520 ± 58 535 ± 137 19.142 ± 976 
1.050 ± 139 1,095 ± 172 741 ± 87 22.416 ± 2.171 
D~ean:t SEM of triplicate cultures at a 2: 1 stimulator responder ratio. Representa-
tive MLR (one oi three) illustrating the responses of two individual chimeric animals. 
Animals are the same as those represented in Table 1 (Chimera 1. 63070 AC1; 
Chimera 2. 20070 ACI). 
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Days Following ACI Cardiac Graft 
Fig. 4. Survival of ACI cardiac grafts in mixed chimeras. syngeneic bone marrow recipients and normal LEW rats. Four weeks 
after bone marrow transplantation, animals received a heterotopic abdominal cardiac graft. Mixed chimeras that failed to 
engraft the allogeneic BM component were analyzed separately (mixed chimera; syngeneic repopulation). 
of the transplanted animals and bone marrow stem 
cells, although Thy-l.l-positive, express few other 
markers of differentiation (20). It is possible that the 
rat, as a recipient, exhibits a greater level of alloresis-
tance to engraftment, because in fully xenogeneic bone 
marrow transplantation we have found that the mouse 
more readily accepts rat bone marrow than the con-
verse (mouse -+ rat). 
The presence of donor-specific transplantation tol-
erance was independent of the percentage of donor 
type cells present in the BM recipient if allogeneic chi-
merism was at all present. This corresponds to findings 
reported in mice (9), and is underscored by the low 
level of chimerism observed in animals 8 and 9, who 
exhibited donor-specific skin graft survival. Previous 
work has already indicated that long-term skin allo-
graft survival was observed only in animals exhibiting 
hematolymphopoietic chimerism. 
Experiments using mixed chimerism to achieve long-
term tolerance to skin grafts were previously conducted 
in congenic mice strains where donor and recipient 
were matched for non-MHC antigens (9). Chronic skin 
graft rejection was reponed when noncongenic mice 
strains were utilized with donor and recipient differing 
in MHC plus nonMHC antigens (9,12). Skin-specific 
antigens were suggested to mediate this rejection, be-
cause animals remained chimeric even after donor-
specific skin graft rejection occurred. The existence of 
tissue-specific antigens expressed selectively on skin, 
but not the bone marrow cells to which the recipient 
was rendered tolerant were first reported by Boyse and 
Olds (3) and Steinmuller (21,22). Mixed allogeneic re-
constitution using noncongenic strain combinations 
(BIO + C3H .., B 10) extended these observations 
(9,12). A recent report from Mayumi and Good (12) 
demonstrated that rejection of skin grafts by noncon-
genic mouse chimeras could be prevented if spleen cells 
were administered with the BMT. In this model, long-
term tolerance to skin grafts was established using a 
combined treatment with mAb, bone marrow and 
spleen cell transplantation, and a single dose of cyclo-
phosphamide. The administration of spleen cells was 
not necessary to induce in vitro tolerance to lymphoid 
cells, but was required to prolong the median survival 
time of the donor type skin grafts from 53 days to 118 
days. Differential survival of skin and heart allografts 
was reponed using TLI followed by allogeneic BM in-
fusion (19). The presence of donor-type lymphoid cells 
was necessary for skin, but not for heart allograft sur-
vival. If this phenomenon is related to the presence of 
skin-specific antigens, the development of suppressor 
cells, or to undetectable levels of chimerism in the hean 
recipients remains unclear. 
Interestingly, in our model for mixed chimerism in 
the rat, there was no evidence for chronic skin or car-
diac graft rejection up to 150 days post BMT. All skin 
I! I! 
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grafts (10/10) and all cardiac grafts (6/6) survived de-
spite transplantation over a MHC plus minor antigen 
disparity. When examined histologically, skin grafts 
had no evidence for chronic rejection. Different strain 
combinations are being evaluated to determine whether 
this is a strain-specific or general effect. Because the 
rat may be more homogeneous in minor histocompat-
ibility antigens in comparison to the mouse (13,14), it 
is possible that minor disparities associated with skin-
specific antigens in the mouse are not great enough in 
the rat to influence expression of these antigens on skin 
cells. Alternatively, skin-specific antigens may not be 
expressed in the rat. 
Induction of tolerance to vascularized organ grafts 
in our rat model was not surprising because donor type 
skin grafts also survived in these chimeric animals. In 
contrast to skin, for the heart there has been no con-
vincing evidence for the presence of tissue-specific an-
tigens that could cause selective rejection of the heart 
in the presence of surviving skin grafts. Testing of dif-
ferent strain combinations will be necessary to evaluate 
survival of heart grafts in other genetic combinations. 
Induction of specific tolerance in the rat supports the 
idea that chimerism might be a useful tool to achieve 
donor-specific transplantation tolerance in higher spe-
cies and possibly in humans. Our present model of 
mixed chimerism in the rat allows testing of a variety 
of vascularized solid organs, such as liver and small 
bowel, which have been performed with limited suc-
cess in the mouse. The existence of well characterized 
strain combinations in genetically inbred rats will al-
low the evaluation for potential organ-specific antigens 
in these specifically tolerant recipients. 
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